Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017:2017:2525967.
doi: 10.1155/2017/2525967. Epub 2017 Jul 12.

Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Affiliations
Review

Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Zewen Liu et al. Oxid Med Cell Longev. 2017.

Abstract

Increasing numbers of individuals, particularly the elderly, suffer from neurodegenerative disorders. These diseases are normally characterized by progressive loss of neuron cells and compromised motor or cognitive function. Previous studies have proposed that the overproduction of reactive oxygen species (ROS) may have complex roles in promoting the disease development. Research has shown that neuron cells are particularly vulnerable to oxidative damage due to their high polyunsaturated fatty acid content in membranes, high oxygen consumption, and weak antioxidant defense. However, the exact molecular pathogenesis of neurodegeneration related to the disturbance of redox balance remains unclear. Novel antioxidants have shown great potential in mediating disease phenotypes and could be an area of interest for further research. In this review, we provide an updated discussion on the roles of ROS in the pathological mechanisms of Alzheimer's disease, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis, and spinocerebellar ataxia, as well as a highlight on the antioxidant-based therapies for alleviating disease severity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic illustrating the key roles of OS in the development of AD, HD, PD, ALS, and SCA. AD: Alzheimer's disease; ALS: amyotrophic lateral sclerosis; Aβ: amyloid beta; BAD: Bcl-2-associated death promoter; CaN: calcineurin; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; HD: Huntington's disease; JNK: c-Jun N-terminal kinase; MAPK: mitogen-activated protein kinase; NFT: neurofibrillary tangle; OS: oxidative stress; PD: Parkinson's disease; SCA: spinocerebellar ataxia; SOD: superoxide dismutase.

Similar articles

Cited by

References

    1. Alzheimer's Association. 2016 Alzheimer's disease facts and figures. Alzheimer's & Dementia. 2016;12:459–509. - PubMed
    1. Silva H. R., Khan N. L., Wood N. W. The genetics of Parkinson's disease. Current Opinion in Genetics & Development. 2000;10:292–298. - PubMed
    1. Albers D. S., Beal M. F. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. Journal of Neural Transmission Supplementum. 2000;59:133–154. - PubMed
    1. Matilla-Duenas A., Ashizawa T., Brice A., et al. Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias. Cerebellum. 2014;13:269–302. - PMC - PubMed
    1. Hamer M., Chida Y. Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychological Medicine. 2009;39:3–11. - PubMed

Substances